Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

EzriCare and Delsam Products Recall: March 2023 Update

March 3, 2023 By Law Offices of Thomas J. Lamb, P.A.

Here is the most recent information from the US Centers for Disease Control and Prevention (CDC) about the EzriCare and Delsam products recall for case reports associated with bacterial contamination:

As of March 1, 2023, CDC, in partnership with state and local health departments, identified 64 patients in 13 states (CA, CO, CT, FL, IL, NJ, NM, NY, NV, TX, UT, WA, WI) with VIM-GES-CRPA, a rare strain of extensively drug-resistant P. aeruginosa. Thirty-seven patients were linked to four healthcare facility clusters. One person has died and there have been 8 reports of vision loss. Dates of specimen collection were from May 2022 to January 2023.

Source: CDC Healthcare-Associated Infections document “Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears” (accessed 3/1/23)

During February 2023 there were recalls of EzriCare and Delsam eye products, specifically:

  1. EzriCare Artificial Tears
  2. Delsam Pharma’s Artificial Tears
  3. Delsam Pharma’s Artificial Eye Ointment

Timeline for Global Pharma Eye Products Recall

  • 2/1/2023: The CDC issued a warning about this Global Pharma eye product, EzriCare Artificial Tears, associated with serious eye infections in patients from various states during recent months.
  • 2/2/2023: Global Pharma initiated a voluntary recall at the consumer level of all unexpired lots of EzriCare Artificial Tears as well as a second Global Pharma eye product, Delsam Pharma’s Artificial Tears.
  • 2/21/2023: First announcement by the FDA about Delsam Pharma’s Artificial Eye Ointment is a warning not to purchase or use this different type of Global Pharma eye product.
  • 2/22/2023: Second announcement by the FDA, one day later, is about a Delsam Pharma’s Artificial Eye Ointment recall by Global Pharma.

For more information, see our earlier articles about this EzriCare and Delsam eye products recall:

Delsam Pharma’s Artificial Eye Ointment Recall February 2023 (2/23/23)

EzriCare and Delsam Pharma’s Eye Drops Products Recall (2/8/23)

EzriCare Artificial Tears Eye Infections Warnings (2/7/23)

We are investigating cases involving hospitalization, death, or permanent vision loss from an infection due to bacterial contamination in connection with this EzriCare and Delsam eye products recall.

Let us know if we can be of assistance to you or someone you know by submitting an online Case Evaluation Form or calling us at 800-426-9535.

[View article at original source]

EzriCare Artificial Tears

Delsam Pharma’s Artificial Tears

Free Case Evaluation

Strictly Confidential, No Obligation

Filed Under: Unsafe Drugs Tagged With: Delsam Pharma’s Artificial Eye Ointment, Delsam Pharma’s Artificial Tears, EzriCare Artificial Tears, vision loss

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.